Coya Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Coya Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2022 to Q3 2024.
  • Coya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $775K, a 195% increase year-over-year.
  • Coya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $2.11M, a 199% increase year-over-year.
  • Coya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $872K, a 321% increase from 2022.
  • Coya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $207K, a 11.1% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.11M $775K +$512K +195% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $1.6M $662K +$471K +247% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.13M $436K +$255K +142% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $872K $238K +$167K +233% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $706K $263K +$193K +276% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 $513K $191K +$146K +328% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $366K $180K +$159K +742% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $207K $71.4K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $69.8K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $44.7K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $21.4K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.